Anzeige
Mehr »
Lynx Broker
Login
Donnerstag, 19.09.2019 Börsentäglich über 12.000 News von 610 internationalen Medien
News des Tages! Größter Cannabisproduzent der Welt legt los.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 4526 ISIN: US36870A1088 Ticker-Symbol:  
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
GEMPHIRE THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
GEMPHIRE THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur GEMPHIRE THERAPEUTICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.08.Gemphire Therapeutics Inc. - 8-K, Current Report-
09.08.Gemphire Therapeutics Inc. - 10-Q, Quaterly Report1
09.08.Gemphire Therapeutics Inc. - 8-K, Current Report-
Börsennews zur GEMPHIRE THERAPEUTICS Aktie und weiteren Hot Stocks erhalten
09.08.Gemphire Therapeutics EPS misses by $0.08-
31.07.Gemphire And Gemcabene: Closure And The End1
26.07.NeuroBo backs onto Nasdaq via merger with Gemphire-
26.07.Boston's NeuroBo to use bruised Gemphire to make Nasdaq debut-
26.07.Gemphire Therapeutics Inc.: Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance ...1
25.07.Mid-Day Market Update: Dow Down 170 Points; Gemphire Therapeutics Shares Spike Higher-
25.07.Gemphire Flirts With $1 Level As Struggling Biotech Strikes Reverse Merger Deal1
25.07.The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug7
25.07.Gemphire Therapeutics Inc. - 8-K, Current Report-
25.07.Gemphire Therapeutics and NeuroBo Pharmaceuticals announce merger agreement2
24.07.Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Company40LIVONIA, Mich. and BOSTON, July 24, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (Gemphire) (Nasdaq: GEMP), a clinical-stage biopharmaceutical company focused on developing therapies for the...
► Artikel lesen
16.07.Gemphire Therapeutics Inc. - S-8, Securities to be offered to employees in employee benefit plans-
26.06.Gemphire Therapeutics Falls 20% After Oral Cholesterol Drug Trial Results-
26.06.Mid-Day Market Update: Crude Oil Up 2.9%; Gemphire Therapeutics Shares Plummet-
26.06.Gemphire down 6% on uneven results from POC study of gemcabene-
26.06.Gemphire Therapeutics Inc. - 8-K, Current Report-
28.05.Gemphire And Gemcabene: The Orphan First Approach Is An Excellent Clinical Refocus1
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1